Delivery Order SPE2DB22D6029-SPE2DB25FLTPC

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $18,726.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 28, 2024 and is a Firm Fixed Price Delivery Order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA). The $122,653.55 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 1, 2024 with a completion date of July 2, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,498.76, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines to the Defense Logistics Agency (DLA). The $33,059.79 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines to the Defense Logistics Agency (DLA). The $3,421.00 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The $1,642.08 firm fixed price delivery order contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,114.11 delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a firm fixed price and an ultimate completion date of November 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order has a ceiling value of $11,799.60 and is a Firm Fixed Price contract. The award does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,084.92, and has an ultimate completion date of July 8, 2024. Amerisourcebergen holds a...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, on a firm fixed price basis. The award, valued at $1,710.50, is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued up to...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTPC
    Delivery Order

This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract, valued at $19,855.67, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The awarded delivery order is likely a task order under this larger IDC contract.

Generated 4/6/25, 12:44 AM